Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Exercise/Conversion of 11,580 ACRS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 11,580 | n/a |
| Jun 9, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 4,793 | n/a |
| Jun 10, 2024 | Aclaris Therapeutics, Inc. (ACRS) | Grant/Award | 15,750 | n/a |
| Jun 4, 2024 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 4,660 | n/a |
| Jun 22, 2023 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 16,500 | $23.3K |
| Jun 20, 2023 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 51 | $36.72 |
| Jun 5, 2023 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 4,507 | n/a |
| Jun 6, 2022 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 3,356 | n/a |
| Jun 5, 2021 | Aclaris Therapeutics, Inc. (ACRS) | Grant/Award | 12,250 | n/a |
| Jun 8, 2020 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 7,333 | n/a |